BioNexus Gene Lab (BGLC) Net Equity Issued and Repurchased (2018 - 2019)
BioNexus Gene Lab (BGLC) reported Net Equity Issued and Repurchased of -$69967.0 for Q4 2019, up 83.7% on a YoY basis from -$38088.6 in Q4 2018, and up 83.7% sequentially from -$429130.0 in Q4 2018.
BioNexus Gene Lab (BGLC) Net Equity Issued and Repurchased (2018 - 2019) Analysis & Trends
BioNexus Gene Lab (BGLC) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$69967.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 3.00 Mn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | - |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | - |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | - |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | - |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | - |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | - |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | - |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | 84.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -69,967.00 |
| Dec 31, 2019 | -69,967.00 |
| Dec 31, 2018 | -429,130.00 |
| Dec 31, 2018 | -429,130.00 |